Killer immune cells that can fight all strains of influenza virus provide the potential for a universal, one-shot flu vaccine

Imagine taking a pill that would help you stave off the flu

NIAID-funded study examines shedding in 320 households during three flu seasons

EMBL scientists investigate how influenza virus responds to new drug treatment

Researchers show that altering the molecular interactions between the flu virus and host genes stunts virus replication

The results of a new experiment refute long-standing studies that indicated the influenza virus degrades and is inactivated sooner as humidity increases

Scientists at The Scripps Research Institute have discovered a new aspect of the flu virus and how it interacts with antibodies in the lungs

Since the start of the 2017-18 flu season in October, the Centers for Disease Control and Prevention has reported over 65,735 positive tests for the virus in the U.S., resulting in hundreds of deaths

Clinical studies examining the association between the use of Tamiflu and neuropsychiatric side effects in children have so far been inconclusive and limited by methodology and potential confounding factors

Immune history influences vaccine effectiveness, interacting with other potential problems arising from the manufacturing process